Detalles de la búsqueda
1.
Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation.
Haematologica;
2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38618681
2.
Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant;
26(5): 1025-1027, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32018063
3.
Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant;
24(1): 142-149, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28951193
4.
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
24(1): 133-141, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28870777
5.
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors.
Haematologica;
108(8): 2234-2239, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36655425
6.
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection.
Biol Blood Marrow Transplant;
23(6): 965-970, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28263918
7.
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies.
Biol Blood Marrow Transplant;
23(11): 2004-2011, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28733264
8.
CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma.
Biol Blood Marrow Transplant;
22(2): 258-267, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26325439
9.
Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib.
Br J Haematol;
190(1): e48-e51, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32358888
10.
Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS/AML.
Blood Adv;
8(3): 553-561, 2024 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096805
11.
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
Clin Lymphoma Myeloma Leuk;
24(2): 83-93, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37827881
12.
Optimization of Older Adults by a Geriatric Assessment-Guided Multidisciplinary Clinic Prior to CAR T-Cell Therapy.
Blood Adv;
2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38810262
13.
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT.
Blood Adv;
7(3): 285-292, 2023 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35851593
14.
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.
Blood Adv;
7(4): 549-554, 2023 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36001442
15.
Knowing the unknowns in high risk multiple myeloma.
Blood Rev;
51: 100887, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34479756
16.
Echocardiographic predictors of new-onset atrial arrhythmias in patients undergoing hematopoietic stem cell transplantation.
Int J Cardiol;
339: 225-231, 2021 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34174337
17.
Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults.
EJHaem;
2(3): 413-420, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35844676
18.
Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients.
Transplant Cell Ther;
27(10): 852.e1-852.e9, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34214736
19.
Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients.
J Geriatr Oncol;
12(4): 585-591, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33162369
20.
Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survival.
Bone Marrow Transplant;
55(6): 1161-1168, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31992847